BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3514390)

  • 41. Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms.
    Kutteh WH; Gall SA; Doellgast GJ; Allitto BA; Dawson JR
    Am J Obstet Gynecol; 1984 Sep; 150(1):65-9. PubMed ID: 6476028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystadenocarcinoma and carcinoembryonic antigen (CEA).
    Ferrer JP; Hensley G; Kalser MH; Zeppa R
    Cancer; 1978 Aug; 42(2):632-4. PubMed ID: 679155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma.
    Teshima H; Kitamura H; Mizoguchi Y; Hino S; Mizutani K; Mori H; Kigawa T
    Gynecol Oncol; 1988 Jul; 30(3):372-80. PubMed ID: 2455679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histogenesis of Brenner tumors, II: histochemistry and CEA.
    Shevchuk MM; Fenoglio CM; Richart RM
    Cancer; 1980 Dec; 46(12):2617-22. PubMed ID: 7004621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An antiserum to ovarian mucinous cyst fluid with colon cancer specificity.
    McNeil C; Ladle JN; Helmick WM; Trentelman E; Wentz MW
    Cancer Res; 1969 Aug; 29(8):1535-40. PubMed ID: 4308954
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.
    Talar-Wojnarowska R; Pazurek M; Durko L; Degowska M; Rydzewska G; Smigielski J; Janiak A; Olakowski M; Lampe P; Grzelak P; Stefanczyk L; Smolarz B; Malecka-Panas E
    Pancreatology; 2012; 12(5):417-20. PubMed ID: 23127529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cystadenoma and cystadenocarcinoma of the liver: localization of carcinoembryonic antigen.
    Tomioka T; Tsuchiya R; Harada N; Tsunoda T; Matsuo T
    Jpn J Surg; 1986 Jan; 16(1):62-7. PubMed ID: 3515006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
    Macdonald F; Bird R; Stokes H; Russell B; Crocker J
    J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.
    Neunteufel W; Breitenecker G
    Gynecol Oncol; 1989 Mar; 32(3):297-302. PubMed ID: 2646183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Parikh F; Lavy G
    Diagn Cytopathol; 1990; 6(3):160-3. PubMed ID: 1696873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
    Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
    Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
    Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical study of carcinoembryonic antigen in mucinous cystic neoplasm of the pancreas.
    Ohta T; Nagakawa T; Fukushima W; Mori K; Kayahara M; Akiyama T; Kanno M; Ueno K; Miyazaki I; Terada T
    Eur Surg Res; 1992; 24(1):37-44. PubMed ID: 1587298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
    de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
    Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamoto R; Yamamura H; Okuda S
    Cancer; 1986 May; 57(9):1836-9. PubMed ID: 2420441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystic neoplasms of the pancreas.
    Yamaguchi K; Enjoji M
    Gastroenterology; 1987 Jun; 92(6):1934-43. PubMed ID: 3471621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic cystic lesions without overt cytologic atypia: proposed diagnostic categories for endoscopic ultrasound-guided fine-needle aspiration cytology with utilization of fluid carcinoembryonic antigen level.
    Madan R; Khan E; Cuka N; Olyaee M; Tawfik O; Fan F
    Acta Cytol; 2012; 56(1):34-40. PubMed ID: 22236743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.